Advertisement

Topics

Companies Related to "AACR 2018 Tumours drug resistance measured times faster" [Most Relevant Company Matches] RSS

04:19 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "AACR 2018 Tumours drug resistance measured times faster" found in our extensive corporate database of over 50,000 company records.

Showing "AACR 2018 Tumours drug resistance measured times faster" Companies 1–25 of 4,300+

Relevant

Gendal Limited

Gendel Limited is developing a safe novel medical device technologu for the treatment of solod cancer tumours in the absence of any drug


Discuva

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The company’s innovative proprietary technologies both identify new small molecule drugs against novel bacterial targets and facilitate their progression through to drug candidates ...

BioAlliance Pharma

BioAlliance Pharma (Euronext Paris: BIO) is an emerging specialty pharmaceutical company focused on the development of innovative therapeutics targeting drug resistance in cancer, HIV, and severe and opportunistic infections.To attack the challenge of resistance, the company has multiple product opportunities in two broad proprietary drug delivery systems represented by the Lauriad® adhesive tech...


Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...

VIRalliance

VIRalliance develops and markets high added value services and products to help optimise drug discovery and patient treatment in the fields of infectious diseases and oncology.VIRalliance has a development portfolio of innovative predictive tests to aid the optimal treatment.PHENOSCRIPT™ is the first of these tests to be made available to the public. PHENOSCRIPT™ is a novel and rapid HIV phen...

NewBiotics

NewBiotics Inc. is a pharmaceutical developer of breakthrough drugs to treat cancer and infectious disease. The privately held company is applying its Enzyme Catalyzed Therapeutic Activation (ECTA) technology to develop a new generation of pharmaceuticals that transform drug resis-tance into therapeutic advantage. Unlike conventional agents that kill diseased cells by enzyme inhibition – with to...

Paratek Pharmaceuticals Incorporated

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has established two product development programs to identify and develop new pharmaceuticals for the treatment of infectious diseases:The Tetracycline Resistance Project ("Tet Project") based on expertise ...

Small Times Media, LLC

Launched in September 2001, Small Times is a controlled circulation print magazine. Small Times magazine details technological advances, applications and investment opportunities to help business leaders stay informed about the rapidly changing business of micro and nanotechnology from biotech to defense, telecom to transportation. Small Times spotlights key issues in the industry's development, a...

High Times

For more than 40 years, High Times —the iconic and authoritative media company in the cannabis business — has been educating the cannabis community by leading the fight for legalization and empowering entrepreneurs in this burgeoning industry. High Times’ content spans digital, social, video and print platforms as well as location-based even...

Pharmacy Times®

Pharmacy Times® is the leading media resource for pharmacists and the pharmacy industry, providing practical clinical and professional information pharmacists can use in their everyday practices when counseling patients and interacting with other health care providers. Each issue and the website contain articles and features covering industry trends, me...

Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for

Barcelona Spine Center

Barcelona Spine Center is a clinic specialising in minimally invasive spinal surgery and neurosurgery. Our specialists have over 15 years of experience and offer safe and effective treatment of a wide range of painful and debilitating conditions of the spine in the state of the art facilities. We operate on a base of a brand new hospital in Barcelona which is currently in a process of attaining I...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

EraGen Biosciences

EraGen products drive diagnostics and drugs to market faster by providing clinical laboratory and drug discovery researchers a high level of accuracy and efficiency. The synergy of our innovative and patented product portfolio gives us a distinct position in the medical marketplace. EraGen patented technologies are at the core of our innovative product portfolio. We continually work to expand our ...

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’s Mission Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving ...

IMBiotechnologies Ltd

IMBio is a privately held Canadian biotechnology company focused on developing medical device products for use in the area of embolotherapy. Lead product, OCL 500 microspheres for the treatment of unresectable/inoperable hypervascularized tumours has received marketing clearance from the FDA in the U.S. Other products in development include rapidly-dissolving, drug-eluting and/or radio-labelle...

DIATOS S.A

Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and dru...

BIOCIUS Life Sciences, Inc.

Tutorial presented by Dr. Vaughn P. Miller: “Increasing the Speed and Efficiency

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known t...

Deciphera Pharmaceuticals, Inc.,

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known t...

Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc.

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the le...

Specialty Pharmacy Times®

Specialty Pharmacy Times® is a leading industry journal serving the business and practice of specialty pharmaceuticals and therapy. Published by Pharmacy Times, the journal focuses on key areas surrounding specialty pharmaceuticals and the enhanced practice needs of pharmacists in this arena. The journal is available at SpecialtyPharmacyTimes.com. ...

Good Times Restaurants Inc.

Good Times is a regional chain of quick-service restaurants, located primarily in Colorado, providing a menu of high-quality all-natural hamburgers, 100% breast of chicken sandwiches, fresh frozen custard, fresh-squeezed lemonades and other unique offerings. Good Times currently operates and franchises 43 restaurants.

ConjuGon

The rise of drug-resistant strains of pathogenic bacteria is quickly becoming a health problem of potentially crisis proportions. Virtually all experts agree that entirely new approaches are needed to go beyond the use of traditional antibiotics. Fundamentally new, even radical, anti-microbial agents are necessary to kill pathogenic bacteria while minimizing the ability of the bacteria to develop ...

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide technology has the potential to set new benchmarks in efficacy and safety with its treatments that are specifically designed to overcome key cancer resistance mechanisms. Acelari...


More From BioPortfolio on "AACR 2018 Tumours drug resistance measured times faster"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks